Gyre Therapeutics (GYRE) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 47.10% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -80.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.42% |
| Dec 31, 2025 | 61.38% |
| Sep 30, 2025 | 39.92% |
| Jun 30, 2025 | -79.54% |
| Mar 31, 2025 | 29.77% |
| Dec 31, 2024 | 83.04% |
| Sep 30, 2024 | 26.92% |
| Jun 30, 2024 | 29.61% |
| Mar 31, 2024 | 32.68% |
| Dec 31, 2023 | -74.81% |
| Sep 30, 2023 | 31.00% |
| Jun 30, 2023 | 28.21% |
| Mar 31, 2023 | 36.69% |
| Dec 31, 2022 | -30.01% |
| Sep 30, 2022 | 27.29% |
| Jun 30, 2022 | 79.12% |
| Mar 31, 2022 | 1.22% |
| Dec 31, 2021 | -23.29% |
| Sep 30, 2021 | -48.58% |
| Jun 30, 2021 | -45.41% |
| Mar 31, 2021 | -64.49% |
| Dec 31, 2020 | -48.68% |
| Sep 30, 2020 | -40.40% |
| Jun 30, 2020 | -20.62% |
| Mar 31, 2020 | 0.69% |
| Dec 31, 2019 | -53.68% |
| Sep 30, 2019 | -38.61% |
| Jun 30, 2019 | -41.80% |
| Mar 31, 2019 | -61.33% |
| Dec 31, 2018 | -18.53% |
| Sep 30, 2018 | -28.67% |
| Jun 30, 2018 | -14.34% |
| Mar 31, 2018 | 9.28% |
| Dec 31, 2017 | -8.09% |
| Sep 30, 2017 | -6.03% |
| Jun 30, 2017 | -6.50% |
| Mar 31, 2017 | 34.90% |
| Dec 31, 2016 | 34.52% |
| Sep 30, 2016 | 28.22% |
| Jun 30, 2016 | 26.90% |
| Mar 31, 2016 | 23.64% |
| Dec 31, 2015 | 25.95% |
| Sep 30, 2015 | 22.89% |
| Jun 30, 2015 | -31.99% |
| Mar 31, 2015 | -70.87% |
| Dec 31, 2014 | 22.55% |
| Sep 30, 2014 | 18.73% |
| Jun 30, 2014 | -53.33% |
| Mar 31, 2014 | -47.23% |
| Dec 31, 2013 | -83.44% |
| Sep 30, 2013 | -93.01% |
| Jun 30, 2013 | -74.03% |